Jim Simons's position in Passage Bio is currently worth $189k. That's 0.00% of their equity portfolio (2729th largest holding). The investor owns 1.48% of the outstanding Passage Bio stock. The first Passage Bio trade was made in Q3 2020. Since then Jim Simons bought shares fifteen more times and sold shares on eight occasions. The investor's estimated purchase price is $2.4M, resulting in a loss of 92%.